Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis

키워드

참고문헌 (48)

1. Johnston CB, "Osteoporosis in older adults", Med Clin North Am, 104, pp.873~884 (2020)[DOI]
2. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update", J Oral Maxillofac Surg, 80, pp.920~943 (2022)[DOI]
3. Tae-Hwan Kim, "Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies", 대한구강악안면외과학회지, 42(4), pp.193~204 (2016), 대한구강악안면외과학회
4. Coskun Benlidayi I, "Oral bisphosphonate related osteonecrosis of the jaw : a challenging adverse effect", ISRN Rheumatol, 2013, pp.215034~ (2013)[DOI]
5. Yoneda T, "Antiresorptive agent-related osteonecrosis of the jaw : position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw", J Bone Miner Metab, 35, pp.6~19 (2017)[DOI]
6. 정호걸, "Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates", Imaging Science in Dentistry, 47(1), pp.45~50 (2017), 대한영상치의학회
7. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)[DOI]
8. 김경민, "Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons", 대한골대사학회지, 22(4), pp.151~165 (2015), 대한골대사학회
9. Anagnostis P, "Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis : EMAS position statement", Maturitas, 101, pp.23~30 (2017)[DOI]
10. Marx RE, "Oral bisphosphonate-induced osteonecrosis : risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)[DOI]
11. Damm DD, "Bisphosphonate-related osteonecrosis of the jaws : a potential alternative to drug holidays", Gen Dent, 61, pp.33~38 (2013)
12. Wutzl A, "Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws", Head Neck, 34, pp.194~200 (2012)[DOI]
13. 강몽헌, "Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw", 대한구강악안면외과학회지, 44(5), pp.225~231 (2018), 대한구강악안면외과학회
14. 김윤호, "Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw", 대한구강악안면외과학회지, 40(5), pp.206~210 (2014), 대한구강악안면외과학회
15. Ramaglia L, "Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws : a systematic review and meta-analysis of the drug suspension protocol", Clin Oral Investig, 22, pp.597~615 (2018)[DOI]
16. Ottesen C, "Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw(MRONJ) : a systematic review", Heliyon, 6, pp.e03795~ (2020)[DOI]
17. Morishita K, "Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients", Sci Rep, 12, pp.11545~ (2022)[DOI]
18. Ruggiero SL, "Diagnosis and staging of medication-related osteonecrosis of the jaw", Oral Maxillofac Surg Clin North Am, 27, pp.479~487 (2015)[DOI]
19. Reich W, "Surgical treatment of bisphosphonate-associated osteonecrosis : prognostic score and long-term results", J Craniomaxillofac Surg, 43, pp.1809~1822 (2015)[DOI]
20. Ihan Hren N, "Spontaneous bone healing of the large bone defects in the mandible", Int J Oral Maxillofac Surg, 37, pp.1111~1116 (2008)[DOI]
21. Moo Soung Park, "Early diagnosis of jaw osteomyelitis by easy digitalized panoramic analysis", Maxillofacial Plastic Reconstructive Surgery, 41(2), pp.1~10 (2019), 대한악안면성형재건외과학회[DOI]
22. Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates : a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)[DOI]
23. Cauley JA, "Estrogen and bone health in men and women", Steroids, 99(Pt A), pp.11~15 (2015)[DOI]
24. Kwon YD, "Bisphosphonate related osteonecrosis of the jaws(BRONJ)in osteoporotic males", Springerplus, 5, pp.1468~ (2016)[DOI]
25. Shibahara T, "Antiresorptive agent-related osteonecrosis of the jaw(ARONJ) : a twist of fate in the bone", Tohoku J Exp Med, 247, pp.75~86 (2019)[DOI]
26. Wang JY, "Skeletal site-specific response of jawbones and long bones to surgical interventions in rats treated with zoledronic acid", Biomed Res Int, 2019, pp.5138175~ (2019)[DOI]
27. Schoenhof R, "Microarchitecture of medication-related osteonecrosis of the jaw(MRONJ); a retrospective micro-CT and morphometric analysis", J Craniomaxillofac Surg, 49, pp.508~517 (2021)[DOI]
28. Mercer E, "Ninety-one osteoporosis patients affected with bisphosphonaterelated osteonecrosis of the jaw : a case series", Calcif Tissue Int, 93, pp.241~248 (2013)[DOI]
29. Kim J, "Comparison of the prescribing pattern of bisphosphonate and raloxifene in Korean women with osteoporosis : from a national health insurance claims database", PLoS One, 10, pp.e0127970~ (2015)[DOI]
30. Figueiredo MA, "Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate", Autops Case Rep, 11, pp.e2020186~ (2020)[DOI]
31. Kim HY, "Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis", J Oral Maxillofac Surg, 75, pp.1404~1413 (2017)[DOI]
32. Mücke T, "Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws", J Cancer Res Clin Oncol, 137, pp.907~913 (2011)[DOI]
33. Okuyama K, "Surgical strategy for medication-related osteonecrosis of the jaw(MRONJ)on maxilla : a multicenter retrospective study", J Dent Sci, 16, pp.885~890 (2021)
34. Wongratwanich P, "Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review", Dentomaxillofac Radiol, 50, pp.20200417~ (2021)[DOI]
35. 서미현, "The effects of pentoxifylline and tocopherol in jaw osteomyelitis", 대한구강악안면외과학회지, 46(1), pp.19~27 (2020), 대한구강악안면외과학회[DOI]
36. Lapić I, "Erythrocyte sedimentation rate and C-reactive protein in acute inflammation", Am J Clin Pathol, 153, pp.14~29 (2020)[DOI]
37. Hawkins D, "How should an increase in alkaline phosphatase activity be interpreted?", Laser Chem, 2007, pp.049608~ (2007)[DOI]
38. Kim SM, "Wound healing protein profiles in the postoperative exudate of bisphosphonaterelated osteonecrosis of mandible", Eur Arch Otorhinolaryngol, 274, pp.3485~3495 (2017)[DOI]
39. Koth VS, "Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy", Dentomaxillofac Radiol, 46, pp.20160260~ (2017)[DOI]
40. Choi SY, "Bone turnover and inflammatory markers of bisphosphonate-related osteonecrosis of the jaw in female osteoporosis patients", J Oral Maxillofac Surg Med Pathol, 25, pp.123~128 (2013)[DOI]
41. Thumbigere-Math V, "Serum markers of bone turnover and angiogenesis in patients with bisphosphonate-related osteonecrosis of the jaw after discontinuation of long-term intravenous bisphosphonate therapy", J Oral Maxillofac Surg, 74, pp.738~746 (2016)[DOI]
42. Webber M, "Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005-2006", Clin Chem Lab Med, 48, pp.167~173 (2010)[DOI]
43. Seo MS, "Relationship between serum alkaline phosphatase level, C-reactive protein and leukocyte counts in adults aged 60 years or older", Scand J Clin Lab Invest, 79, pp.233~237 (2019)[DOI]
44. Taniguchi N, "Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts : a pathogenesis of bisphosphonate-related osteonecrosis of the jaw", J Periodontol, 91, pp.947~955 (2020)
45. Liu D, "Parathyroid hormone-related protein inhibits nitrogen-containing bisphosphonate-induced apoptosis of human periodontal ligament fibroblasts by activating MKP1 phosphatase", Bioengineered, 12, pp.1997~2006 (2021)[DOI]
46. Lee SS, "Extensive protein expression changes induced by pamidronate in RAW 264. 7 cells as determined by IP-HPLC", PeerJ, 8, pp.e9202~ (2020)[DOI]
47. Hess DR, "Retrospective studies and chart reviews", Respir Care, 49, pp.1171~1174 (2004)
48. Gearing RE, "A methodology for conducting retrospective chart review research in child and adolescent psychiatry", J Can Acad Child Adolesc Psychiatry, 15, pp.126~134 (2006)

관련 논문AI추천